Loco-regional treatments on the liver transplant waiting list: unmasking hepatocellular carcinoma (HCC) biology

Amine Benmassaoud^{1

2}, Emmanuel A Tsochatzis^{1

2}

Affiliations

¹ UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
² Sheila Sherlock Liver Unit, Royal Free Hospital, London, UK.

Editorial

Amine Benmassaoud et al. Hepatobiliary Surg Nutr. 2018 Jun.

. 2018 Jun;7(3):199-201.

doi: 10.21037/hbsn.2018.02.03.

Amine Benmassaoud^{1

2}, Emmanuel A Tsochatzis^{1

2}

¹ UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
² Sheila Sherlock Liver Unit, Royal Free Hospital, London, UK.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
Agopian VG, Harlander-Locke MP, Ruiz RM, Klintmalm GB, Senguttuvan S, Florman SS, Haydel B, Hoteit M, Levine MH, Lee DD, Taner CB, Verna EC, Halazun KJ, Abdelmessih R, Tevar AD, Humar A, Aucejo F, Chapman WC, Vachharajani N, Nguyen MH, Melcher ML, Nydam TL, Mobley C, Ghobrial RM, Amundsen B, Markmann JF, Langnas AN, Carney CA, Berumen J, Hemming AW, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Busuttil RW. Agopian VG, et al. Ann Surg. 2017 Sep;266(3):525-535. doi: 10.1097/SLA.0000000000002381. Ann Surg. 2017. PMID: 28654545

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108. 10.3322/caac.21262 - DOI - PubMed
1. Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012;57:675-88. 10.1016/j.jhep.2012.04.015 - DOI - PubMed
1. Tsochatzis EA, Germani G, Burroughs AK. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment. Semin Oncol 2010;37:89-93. 10.1053/j.seminoncol.2010.03.007 - DOI - PubMed
1. Yao FY, Bass NM, Nikolai B, et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003;9:684-92. 10.1053/jlts.2003.50147 - DOI - PubMed
1. Lesurtel M, Mullhaupt B, Pestalozzi BC, et al. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant 2006;6:2644-50. 10.1111/j.1600-6143.2006.01509.x - DOI - PubMed